Video - Results from #40

ASCO 2022 VL

Treatment with Radium-223 and Effects on Bone Health in Patients with mCRPC - Fred Saad Details In this conversation, Fred Saad and Alicia Morgans discuss the critical role of bone health in treating patients with metastatic castration-resistant prostate cancer (mCRPC), particularly when using radium. Dr. Saad highlights that while newer cancer treatments like enzalutamide and abiraterone have been effective, they shouldn't overshadow the importance of bone health. He points to the PEACE III...
Identifying the Right Patients for Treatment with Radium-223 for mCRPC - Brenda Martone Details Brenda Martone and Alicia Morgans delve into the nuanced use of Radium for treating patients with metastatic CRPC (Castration-Resistant Prostate Cancer). Dr. Martone emphasizes that Radium is not just for alleviating bone pain but can also address other symptoms like fatigue and loss of appetite. She notes that the drug can be used at any point in the treatment continuum, depending on patient need...